Skip to main content

Good news as WHO unveils drug to tackle excessive bleeding at childbirth

The World Health Organisation (WHO) says a new drug – Carbetocin – has the potential to save thousands of women’s lives in childbirth annually.

WHO said Carbetocin now serves as a new competition – with improved benefits – to Oxytocin, a standby drug used to prevent potentially-fatal bleeding after childbirth.

WHO said excessive bleeding after childbirth still kills around 70,000 mothers a year and currently, Oxytocin is the first-choice medication, but it must be kept cold, unlike the new drug, Carbetocin.

The study, partly led, among others, by WHO and published on Wednesday, suggested that the new drug which could be stored at normal temperatures, could save the lives of thousands in low- and lower-middle-income countries.

“This is a truly encouraging new development that can revolutionise our ability to keep mothers and babies alive,” said WHO Director-General Tedros Adhanom Ghebreyesus.

WHO said since Oxytocin must be stored and transported at a cool two to eight degrees Celsius – a difficult task in many countries – numerous women lack access to the medicine.

The global health agency said even if women could obtain Oxytocin, heat exposure might render the drug less effective.

The study, published in the New England Journal of Medicine, has shown the heat-stable Carbetocin is not only as safe and effective as Oxytocin but even without refrigeration – when stored at below 30 degrees Celsius and 75 percent relative humidity – it retains its efficacy for at least three years.

In the largest clinical trial of its kind, close to 30,000 women who gave birth vaginally were studied in Nigeria, Argentina, Egypt, India, Kenya, Singapore, South Africa, Thailand, Uganda and the United Kingdom.

Immediately after childbirth, each woman was randomly injected with a single dose of either heat-stable Carbetocin or Oxytocin – revealing that both were equally effective at preventing excessive bleeding.

Metin Gülmezoglu of WHO’s Department of Reproductive Health and Research described the report of Carbetocin as “very good news” for millions of women.

“The development of a drug to prevent postpartum haemorrhage that continues to remain effective in hot and humid conditions is very good news for the millions of women who give birth in parts of the world without access to reliable refrigeration,” Gülmezoglu said.

While Carbetocin has not yet been cleared for use beyond clinical trials, the next steps begin with a regulatory review, countries’ approval and then consideration by WHO’s Guideline Development Group.

However, WHO said that following the positive trial results, it would be working to advance affordable access to the potentially lifesaving drug in countries with a high maternal death rate.

Comments

Post a Comment

Popular posts from this blog

Vulvar Care Tips

Vulva Care Maintaining a healthy vulva and vagina will help prevent infections and discomfort. Unusual changes in vaginal discharge is a sign that there might be an issue. Why is vulvar and vagina care important? Many women experience uncomfortable, vaginal infections (vaginitis) at one time or another. The area around the entrance to the vagina (vulva) can also become irritated. Steps can be taken to relieve and prevent vulvar discomfort and vaginal infections. Not all vaginal infections are alike and home treatments can worsen some types. If you have any concerns about your vulvar or vaginal health, or notice unusual changes in vaginal discharge, contact your healthcare provider if the problem persists. What is the vulva? The vulva is the area of female sex organs that lies outside of the vagina. These organs include folds of sensitive tissue called the labia (labia means "lips"). The labia has two parts. The outermost folds are called the labia majora. A secon...
Post a Comment
Read more

Nigeria’s first female banker, Sarah Morocco-Clarke is dead

Sarah Adenike Morocco-Clarke, Nigeria’s first female banker is dead. Morocco-Clarke died at the age of 80 on Sunday, 16 September 2018, after a short illness. Sarah Morocco-Clarke, an alumnus of Queen’s College Lagos, started her career with First Bank (then Bank of British West Africa, and subsequently Standard Bank) as a pioneer female employee, and rose through the ranks at First Bank Nigeria and was made the Services Manager and Secretary to the South Administration, wherein she had a mandate that covered the services of all the First Bank branches in Southern Nigeria. While she worked in the banking industry, she was manager of numerous First Bank branches in Lagos and was subsequently made a Regional Manager in charge of Bendel, Ogun and Oyo states. She was also an Area Manager in the Western part of Nigeria. Popularly known as the ‘Iron Lady, Morocco-Clarke leaves behind six successful children, thirteen grandchildren and three great-grandchildren.
Post a Comment
Read more

BBNaija winner, Miracle, gets Pilot license

The winner of the BBNaija ‘Double Wahala’ reality show, Miracle Ikechukwu, has obtained his Private Pilot License and Flight Dispatcher License. The 23-year-old took to his Instagram page to share the news by posting a picture of his licenses alongside birthday wishes for his mother. He wrote, “Today is also my pillar’s birthday (my sweet mum). Thank you, mother, for always being there for me through the journey. “To all my lovely fans, I thank you all for your patience and support. We made it. PPL in the bag. Happy new month,” Miracle said. During the course of the BBNaija show, Miracle, who was in aviation school prior to the show, continually expressed his desire to obtain all piloting licenses as soon as possible. He expressed his resolve during the eviction nights where he wore his piloting uniform each time he was up for possible eviction. Miracle’s total winning prize included N25m cash, a Sub-Urban Vehicle worth N12m and a trip for two valued N4.7m, Television an...
Post a Comment
Read more